$BRO

Brown & Brown Reports 7.4% Revenue Growth and $1.07 Adjusted EPS

Brown & Brown reported Q3 2026 revenue of $1.725B, up 7.4% YoY, with organic growth of 1.2%. Adjusted EPS was $1.07. Net income rose 5.7% to $240M. CEO J. Powell Brown cited customer gains despite a tough rate environment. The company expanded via the Accession acquisition, adding 5,000 employees.

Original reporting
Published Oct 26, 2026, 9:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Brown & Brown Reports 7.4% Revenue Growth and $1.07 Adjusted EPS — source image
Decision brief

The 30-second read

$BROBullishHigh
01

Why it matters

The earnings release provides fresh financial metrics that can shift investor expectations.

02

Market read

First‑report earnings with revenue growth and adjusted EPS beat could move BRO's stock in after‑hours trading.

03

What to watch

Potential headwinds from rate environment and underwriting cycles not detailed.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Brown & Brown is a U.S. insurance brokerage that filed its Q3 2026 earnings via an 8‑K.

Company-level read

Ticker impact

$BROBullishHigh confidence
Context

Q3 2026 earnings released with 7.4% revenue growth and $1.07 adjusted EPS.

Expected impact

potential upside as market prices in stronger top‑line and EPS

Evidence & confidence

First‑report earnings show solid growth; no negative guidance, likely to attract buying.

Market effects

Insurance brokerage sector may see broader confidence from BRO's results.

U.S. market participants may adjust exposure to property‑casualty insurers.

Limited to U.S. insurers; minimal global ripple.

Counterpoint

If guidance is flat, the stock could face profit‑taking despite top‑line growth.

Key entities

  • Brown & Brown

    Insurance brokerage reporting Q3 results.

  • J. Powell Brown

    CEO commenting on customer wins.

Related articles

$BROMed

Brown & Brown Inc (BRO) (Q3 2026) Earnings Call Highlights: Revenue Up 7.4%

Brown & Brown Inc (BRO) reported Q3 2026 revenue up 7.4% to $1.07B, but adjusted EBITDAC margin fell 200 bps to 34.6%. Specialty Distribution organic revenue declined 0.8%, missing expectations due to competition and pricing pressures. The company anticipates further declines in Q4 and faces ongoing litigation impacts. Integration costs for Accession have increased to $250-300M.

$BROMed

What Brown & Brown (BRO) Said on Its Q3 Earnings Call

Brown & Brown (BRO) reported Q3 earnings, noting market shifts in California and Texas, and pricing pressures in commercial earthquake business. The company expects 2027 growth of 2%-4% for retail and 1%-3% for specialty distribution. Accession acquisition raised synergy targets to $50M for 2026 and $175M by 2028. AI initiatives are expanding across the company, with tools like Claude and COMPASS being deployed. The board increased the dividend by 9%.

$BROHighAI 8/10

Brown & Brown (BRO) Q3 2026 Earnings Call Transcript

Brown & Brown (BRO) reported Q3 2026 revenues of $1.7B, up 7.4% YoY. Organic revenue grew 1.2%, while adjusted EBITDAC margin fell 200 bps to 34.6%. Adjusted EPS rose 2% to $1.07. The company raised its dividend by 9%, marking 33 consecutive years of increases. Retail segment outperformed expectations, while specialty distribution faced headwinds. The company repurchased $750M in shares YTD, including $250M in Q3.

$BROMed

Truist cuts Brown & Brown stock price target to $85 on lower estimates

Truist Securities reduced its price target for Brown & Brown (NYSE:BRO) to $85 from $90, citing lower 2026 and 2027 EPS estimates. The firm maintained a Buy rating, basing the target on a 14x multiple of its 2027 EBITDA estimate. BRO's Q3 earnings missed expectations, with revenue at $1.72B and EPS at $1.07, though both showed year-over-year growth. The company's organic growth slowed, and its adjusted EBITDAC margin declined by 200 basis points.

$BROMed

Why Brown & Brown (BRO) stock is trading lower today

Brown & Brown (BRO) shares fell 4.9% after reporting Q3 2026 revenue of $1.73B, up 7.4% YoY, but with slowing organic growth and margin compression. CEO Powell Brown noted declines in excess-and-surplus property rates and expected further decreases in 2027. The stock is down 13.4% YTD, trading at $67.25, 23.4% below its 52-week high.